Clinical implications of the margin cytology findings and margin/tumor size ratio in patients who underwent pulmonary excision for peripheral non-small cell lung cancer

被引:55
作者
Sawabata, Noriyoshi [1 ]
Maeda, Hajime [1 ]
Matsumura, Akihide [1 ]
Ohta, Mitsunori [1 ]
Okumura, Meinoshin [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Gen Thorac Surg, Suita, Osaka 5650871, Japan
关键词
Non-small cell lung cancer; Pulmonary excision; Margin cytology; Margin/tumor ratio; Prognosis; SUBLOBAR RESECTION; BRONCHOGENIC-CARCINOMA; SEGMENTAL RESECTION; LIMITED RESECTION; SEGMENTECTOMY; LOBECTOMY;
D O I
10.1007/s00595-011-0031-6
中图分类号
R61 [外科手术学];
学科分类号
摘要
A pulmonary wedge resection is useful for the treatment of peripheral non-small cell lung cancer (NSCLC). The margin/tumor size ratio (M/T) is a predictor of positive margin cytology findings in these procedures, although the long-term clinical implications remain unclear. This relationship was investigated in this study. Thirty-seven cases with a high surgical risk without additional pulmonary resection were selected from those accrued in a multicenter prospective study of optimal margin distance for pulmonary excision of peripheral NSCLC and followed for more than 5 years (range 5.3-14 years). Both the M/T and margin cytology findings were indicators of cancer recurrence and survival. All seven cases of surgical margin recurrence had a cytology-positive surgical margin. The 5-year survival rate was 54.2% (n = 24) for M/T < 1 and 84.6% for M/T a parts per thousand yen 1 (n = 13, P = 0.05), while it was 38.5% for positive margin (n = 13) and 79.2% for negative margin (n = 24) cases (P = 0.001). In addition, the margin cytology findings were an independent prognostic factor. A pulmonary wedge resection for peripheral NSCLC should result in a negative malignant margin, which might be obtained from a sufficient tumor margin ratio of M/T a parts per thousand yen 1.
引用
收藏
页码:238 / 244
页数:7
相关论文
共 23 条
[1]  
[Anonymous], CALGB140503 NIH NAT
[2]   Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: A 13-year analysis [J].
El-Sherif, Amgad ;
Gooding, William E. ;
Santos, Ricardo ;
Pettiford, Brian ;
Ferson, Peter F. ;
Fernando, Hiran C. ;
Urda, Susan J. ;
Luketich, James D. ;
Landreneau, Rodney J. .
ANNALS OF THORACIC SURGERY, 2006, 82 (02) :408-416
[3]  
ERRETT LE, 1985, J THORAC CARDIOV SUR, V90, P656
[4]   Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer [J].
Fernando, HC ;
Santos, RS ;
Benfield, JR ;
Grannis, FW ;
Keenan, RJ ;
Luketich, JD ;
Close, JM ;
Landreneau, RJ .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 129 (02) :261-267
[5]   Small peripheral lung adenocarcinoma: Clinicopathological features and surgical treatment [J].
Fukui, Takayuki ;
Mitsudomi, Tetsuya .
SURGERY TODAY, 2010, 40 (03) :191-198
[6]   Intraoperative lavage cytologic analysis of surgical margins in patients undergoing limited surgery for lung cancer [J].
Higashiyama, M ;
Kodama, K ;
Takami, K ;
Higaki, N ;
Nakayama, T ;
Yokouchi, H .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (01) :101-107
[7]  
JENSIK RJ, 1973, J THORAC CARDIOV SUR, V66, P563
[8]   Segmental resection spares pulmonary function in patients with stage I lung cancer [J].
Keenan, RJ ;
Landreneau, RJ ;
Maley, RH ;
Singh, D ;
Macherey, R ;
Bartley, S ;
Santucci, T .
ANNALS OF THORACIC SURGERY, 2004, 78 (01) :228-233
[9]   Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: A single-institution study [J].
Kodama, K ;
Doi, O ;
Higashiyama, M ;
Yokouchi, H .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 114 (03) :347-353
[10]   Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer [J].
Landreneau, RJ ;
Sugarbaker, DJ ;
Mack, MJ ;
Hazelrigg, SR ;
Luketich, JD ;
Fetterman, L ;
Liptay, MJ ;
Bartley, S ;
Boley, TM ;
Keenan, RJ ;
Ferson, PF ;
Weyant, RJ ;
Naunheim, KS .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 113 (04) :691-700